F-36P cells
Catalog #:
C0003014
Shipping advice:
Use only Express Delivery (overnight) for cell line. International shipping rate please contact us for details
Frozen vial | USD450.0 |
Disease:
Acute myeloid leukemia, myelodysplastic syndrome
Origin:
Established at diagnosis of a 68-year-old male with acute myeloid leukemia (AML M6) secondary to myelodysplastic syndrome (MDS, subtype refractory anemia with excess of blasts, RAEB) in 1989; cells were described to be proliferatively responsive to GM-CSF and IL-3. Cells have been shown to synthesize haemoglobin when GM-CSF or IL-3 is substituted by erythropoietin (Epo). They have been reported to be positive for leukocyte common antigen (CD45) and some multilineage markers such as CD13, CD33 and CD34, but are negative for T- and B-cell antigens and mature myelomonocytic antigens. Due to their reaction with some monoclonal antibodies recognising erythroid and platelet glycoproteins it has been suggested that F-36P has a multilineage phenotype.
Species:
Homo sapiens
Pleural effusion
Lymphoblastoid
Polymorph cells growing as adherent cells and singly in suspension
human flat-moded hypodiploid karyotype with 6% polyploidy - 41(40-43)<2n>XY, -3, -13, -16, -19, -21, -22, +2mar, ins(X;13)(p11;q?q?), del(3)(p13p24), add(5)(q11), dup(5)(q11q35), der(6)add(6)(p23)dup(6)(q25q27), der(7)add(7)(p13)add(7)(q12), add(9)(q35), der(9)del(9)(q11q34)inv(9)(p2?4;q34), der(10)t(8;10)(q24;p14)t(10;7)(q25;q12), del(11)(q14q21), der(21)t(10;21)(p14;p12) - sideline with dup(1)(p35p36), dup(2)(q1?q2?), del(3)(p13p24) - matches published karyotype
Male, 68 yrs of age
RPMI-1640 Medium + 20% FBS + 10 ng/mL GM-CSF or 5 ng/mL rh IL-3
Subculture saturated culture 1:3 to 1:8 every 2-5 days; seed out at ca. 0.3-0.5 x 10^6 cells/ml; maintain at ca. 1.0 x 10^6 cells/ml; maximum density at ca. 1.8 x 10^6 cells/ml. Upon cytokine withdrawal cells do not die but undergo a stationary survival status. REMARKS: by favoring selective growth, suboptimal culture of cytokine-dependent cell lines may promote growth of factor-independent subclones. Selective conditions include cytokine insufficiency and inadequate cell density. Therefore, we cannot guarantee indefinite stability of factor-dependence of cell lines. Culture at 5% CO2; 37°C
Complete culture medium supplemented with 7.5% (v/v) DMSO I
Bacteria: Negative
Yeast: Negative
Mycoplasma: Negative
HIV: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Amelogenin: X,Y
CSF1PO: 9
D13S317: 10
D16S539: 10,12
D5S818:13
D7S820: 9,11
THO1:8
TPOX: 9,11
vWA: 14,16
If use of this culture results in a scientific publication, it should be cited in the publication as: F-36P (AddexBio C0003014)
Tissue:
Morphology:
Properties:
Cytogenic data:
Patient:
Medium:
Subculture:
Freezing Medium:
Biosafety Level:
Sterility:
Pathogens:
DNA Profile (STR):
Citation Format:
References for F-36P cells:
1. Chiba S, Takaku F, Tange T, Shibuya K, Misawa C, Sasaki K, Miyagawa K, Yazaki Y, Hirai H. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. Blood 1991; 79 ( 9 ): 2261-2268. http://www.ncbi.nlm.nih.gov/pubmed/1834251